Literature DB >> 22955700

Influence of IL17A polymorphisms (rs2275913 and rs3748067) on the susceptibility to ulcerative colitis.

Ranji Hayashi1, Tomomitsu Tahara, Hisakazu Shiroeda, Takashi Saito, Masakatsu Nakamura, Mikihiro Tsutsumi, Tomoyuki Shibata, Tomiyasu Arisawa.   

Abstract

Interleukin-17A plays a role in tissue inflammation by inducing release of proinflammatory and neutrophil-mobilizing cytokines. We investigated the association between ulcerative colitis (UC) and polymorphisms of IL17A, rs2275913 (-197 G > A), and rs3748067 (*1249 C > T). The study was performed in 475 healthy subjects (controls) and 202 with UC (UC cases), including 113 controls and 64 UC cases from previous study. We employed the multiplex PCR-SSCP method to detect gene polymorphisms. The minor allele frequency of rs2275913 was significantly higher but that of rs3748067 was significantly lower in UC cases than controls. The rs2275913 minor homozygote (AA) had an increased risk of the development of UC, whereas rs3748067 minor carrier (CT + TT) had decreased risks for the development of UC. When compared with LR group (rs2275913 GG + GA with rs3748067 CT + TT), HR group (rs2275913 AA with rs3748067 CC) had a more increased risk of the development of UC (OR, 3.38; p = 0.0007). The polymorphisms of IL17A were associated with the noncontinuous and pancolitis phenotypes of UC. Our results suggest that IL17A polymorphisms (both rs2275913 and rs3748067) influence the susceptibility to and pathophysiological features of UC, coordinately.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22955700     DOI: 10.1007/s10238-012-0206-5

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  28 in total

Review 1.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

2.  Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17.

Authors:  Sudeepta Aggarwal; Nico Ghilardi; Ming-Hong Xie; Frederic J de Sauvage; Austin L Gurney
Journal:  J Biol Chem       Date:  2002-11-03       Impact factor: 5.157

3.  Association between functional promoter polymorphisms of macrophage migration inhibitory factor (MIF) gene and ulcerative colitis in Japan.

Authors:  Hisakazu Shiroeda; Tomomitsu Tahara; Masakatsu Nakamura; Tomoyuki Shibata; Tomoe Nomura; Hideto Yamada; Ranji Hayashi; Takashi Saito; Masayoshi Yamada; Tomoki Fukuyama; Toshimi Otsuka; Hirokazu Yano; Kazuaki Ozaki; Mutsumi Tsuchishima; Mikihiro Tsutsumi; Tomiyasu Arisawa
Journal:  Cytokine       Date:  2010-08       Impact factor: 3.861

4.  Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases.

Authors:  Mathias Chamaillard; Dana Philpott; Stephen E Girardin; Habib Zouali; Suzanne Lesage; Fabrice Chareyre; The Hung Bui; Marco Giovannini; Ulrich Zaehringer; Virginie Penard-Lacronique; Philippe J Sansonetti; Jean-Pierre Hugot; Gilles Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-07       Impact factor: 11.205

5.  Ulcerative colitis: factors affecting difficulties of life and psychological well being of patients in remission.

Authors:  Makoto Tanaka; Keiko Kazuma
Journal:  J Clin Nurs       Date:  2005-01       Impact factor: 3.036

Review 6.  After interleukin-12p40, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease?

Authors:  Zili Zhang; David J Hinrichs; Huiying Lu; Hong Chen; Wenwei Zhong; Jay K Kolls
Journal:  Int Immunopharmacol       Date:  2006-11-13       Impact factor: 4.932

7.  Prospects for research in inflammatory bowel disease.

Authors:  R S Blumberg; W Strober
Journal:  JAMA       Date:  2001-02-07       Impact factor: 56.272

Review 8.  Interleukin-17 family members and inflammation.

Authors:  Jay K Kolls; Anders Lindén
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

Review 9.  MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine.

Authors:  Prasun J Mishra; Joseph R Bertino
Journal:  Pharmacogenomics       Date:  2009-03       Impact factor: 2.533

10.  Association between polymorphisms in interleukin-17A and interleukin-17F genes and risks of gastric cancer.

Authors:  Xiaoqin Wu; Zhirong Zeng; Bin Chen; Jun Yu; Ling Xue; Yuantao Hao; Minhu Chen; Joseph J Y Sung; Pinjin Hu
Journal:  Int J Cancer       Date:  2010-07-01       Impact factor: 7.396

View more
  19 in total

1.  IL-17A G197A gene polymorphism contributes to susceptibility for liver cirrhosis development from patients with chronic hepatitis B infection in Chinese population.

Authors:  Jian Ge; Yuan-Zi Yu; Tao Li; Zhao-Yang Guo; Hao Wu; Shao-Can Tang; Xin-Guang Liu; Qiang Zhu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

2.  Association of inflammatory cytokine gene polymorphisms with inflammatory bowel disease in a Moroccan cohort.

Authors:  N Senhaji; A Serrano; W Badre; N Serbati; M Karkouri; Y Zaid; S Nadifi; J Martin
Journal:  Genes Immun       Date:  2015-12-03       Impact factor: 2.676

3.  StIL-17 gene polymorphisms in the development of pulmonary tuberculosis.

Authors:  Jin Du; Jichang Han; Xiandong Li; Yajun Zhang; Hongbing Li; Shujuan Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

4.  Genetic variants of interleukin 17A are functionally associated with increased risk of age-related macular degeneration.

Authors:  Shaoru Zhang; Yonghua Liu; Shilin Lu; Xinmeng Cai
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

Review 5.  Interleukin-17 SNPs and serum levels increase ulcerative colitis risk: a meta-analysis.

Authors:  Juan Li; Hao Tian; Hui-Jun Jiang; Bin Han
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

6.  IL12B and IL23R polymorphisms are associated with alopecia areata.

Authors:  Pardis-Sadat Tabatabaei-Panah; Hamideh Moravvej; Sara Delpasand; Mona Jafari; Sanaz Sepehri; Reyhaneh Abgoon; Ralf J Ludwig; Reza Akbarzadeh
Journal:  Genes Immun       Date:  2020-05-01       Impact factor: 2.676

7.  Association study between IL-17A and IL-17F gene polymorphism and myasthenia gravis in Chinese patients.

Authors:  Yao-Xian Yue; Yu Hong; Yanchen Xie; Hong-Jun Hao; Yi Sui; Chuan-Kai Gu; Xu Zhang; Xiang Gao; Tian-Ping Tang; Xian-Jun Zhang; Qi Wang; Hai-Feng Li
Journal:  Neurol Sci       Date:  2015-09-04       Impact factor: 3.307

8.  Fusobacterium detected in colonic biopsy and clinicopathological features of ulcerative colitis in Japan.

Authors:  Tomomitsu Tahara; Tomoyuki Shibata; Tomohiko Kawamura; Masaaki Okubo; Yuichiro Ichikawa; Kazuya Sumi; Masahiro Miyata; Takamitsu Ishizuka; Masakatsu Nakamura; Mitsuo Nagasaka; Yoshihito Nakagawa; Naoki Ohmiya; Tomiyasu Arisawa; Ichiro Hirata
Journal:  Dig Dis Sci       Date:  2014-08-08       Impact factor: 3.199

Review 9.  Characteristics of Japanese inflammatory bowel disease susceptibility loci.

Authors:  Yoshiaki Arimura; Hiroyuki Isshiki; Kei Onodera; Kanna Nagaishi; Kentaro Yamashita; Tomoko Sonoda; Takayuki Matsumoto; Atsushi Takahashi; Masakazu Takazoe; Keiko Yamazaki; Michiaki Kubo; Mineko Fujimiya; Kohzoh Imai; Yasuhisa Shinomura
Journal:  J Gastroenterol       Date:  2013-08-13       Impact factor: 7.527

Review 10.  The IL23-IL17 Immune Axis in the Treatment of Ulcerative Colitis: Successes, Defeats, and Ongoing Challenges.

Authors:  Daniele Noviello; Riccardo Mager; Giulia Roda; Riccardo G Borroni; Gionata Fiorino; Stefania Vetrano
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.